dichloromethotrexate
Term · Oncology and biomedicine · MLC-T-ONC-013040
A chlorinated methotrexate derivative. Dichloromethotrexate inhibits the enzyme dihydrofolate reductase, thereby preventing the synthesis of purine nucleotides and thymidylates and inhibiting DNA and RNA synthesis. This agent is metabolized and excreted by the liver.
| Identifier | MLC-T-ONC-013040 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | DCM |
| Synonyms | dichloroamethopterin; methotrexate, dichloro |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013040",
"term": "dichloromethotrexate",
"field": "Oncology and biomedicine",
"definition": "A chlorinated methotrexate derivative. Dichloromethotrexate inhibits the enzyme dihydrofolate reductase, thereby preventing the synthesis of purine nucleotides and thymidylates and inhibiting DNA and RNA synthesis. This agent is metabolized and excreted by the liver.",
"abbreviation": "DCM",
"synonyms": [
"dichloroamethopterin",
"methotrexate, dichloro"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/dichloromethotrexate/"
}
Record 5,958 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.